Terns Pharmaceuticals has a total of 555 patents globally, out of which 135 have been granted. Of these 555 patents, 76.75%patents are active. United States of America is where Terns Pharmaceuticals has filed the maximum number of patents, followed by Europe (EPO) and Japan. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Terns Pharmaceuticals.
Founded in 2016, Terns Pharmaceuticals is a clinical-stage biopharmaceutical company focused on discovering and developing innovative therapies for diseases with significant unmet medical needs. The company leverages its expertise in drug discovery and development to advance novel treatments across areas including oncology and metabolic diseases. Terns is committed to developing differentiated therapies that improve patient outcomes and address challenging diseases.
On May 5, 2026, Merck completed its acquisition of Terns Pharmaceuticals, expanding its hematology and oncology pipeline with TERN-701, an investigational therapy for chronic myeloid leukemia (CML). The acquisition combines Terns’ clinical-stage expertise with Merck’s global R&D capabilities, strengthening its position in innovative cancer therapies. This milestone reinforces Merck’s commitment to advancing differentiated treatments and addressing significant unmet medical needs.
Do read about some of the most notable patents of Terns Pharmaceuticals covered in this article. You can also explore Terns Pharmaceuticals’ patent portfolio, worldwide patent filing activity, patent filing trends over the years, and many other statistics related to its patent portfolio.
How many patents does Terns Pharmaceuticals have?
Terns Pharmaceuticals has a total of 555 patents globally. These patents belong to 41 unique patent families. Out of 555 patents, 426 patents are active.
How Many Patents did Terns Pharmaceuticals File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Terns Pharmaceuticals Applications Filed | Terns Pharmaceuticals Patents Granted |
| 2026 | 10 | 54 |
| 2025 | 40 | 45 |
| 2024 | 79 | 20 |
| 2023 | 46 | 7 |
| 2022 | 102 | 3 |
| 2021 | 108 | 5 |
| 2020 | 43 | 1 |
| 2019 | 113 | – |
| 2018 | 14 | – |
How many Terns Pharmaceuticals patents are Alive/Dead?
Worldwide Patents
How Many Patents did Terns Pharmaceuticals File in Different Countries?
Countries in which Terns Pharmaceuticals Filed Patents
| Country | Patent |
| United States of America | 52 |
| Europe (EPO) | 33 |
| Japan | 32 |
| China | 30 |
| Australia | 28 |
| Canada | 26 |
| Hong Kong (S.A.R.) | 25 |
| Taiwan | 22 |
| Israel | 21 |
| Mexico | 19 |
| Singapore | 18 |
| New Zealand | 17 |
| South Africa | 17 |
| Chile | 16 |
| Korea (South) | 15 |
| Peru | 15 |
| Brazil | 15 |
| Malaysia | 15 |
| India | 14 |
| Eurasia | 11 |
| Colombia | 9 |
| Germany | 5 |
| Spain | 5 |
| Finland | 4 |
| Serbia | 4 |
| Albania | 4 |
| Croatia | 4 |
| Denmark | 4 |
| Italy | 4 |
| Austria | 4 |
| Argentina | 4 |
| Portugal | 4 |
| Lithuania | 3 |
| Poland | 3 |
| Slovenia | 3 |
| Morocco | 3 |
| Turkey | 3 |
| Russia | 3 |
| Republic of Moldova | 2 |
| Hungary | 1 |
| Malta | 1 |
| Norway | 1 |
| Macao | 1 |
Track Every Patent Move in Real Time Across 70+ Jurisdictions with Elixir
Where are Research Centres of Terns Pharmaceuticals Patents Located?
10 Best Terns Pharmaceuticals Patents
WO2022040600A1 is the most popular patent in the Terns Pharmaceuticalsportfolio. It has received 88 citations so far from companies like Gilead Sciences and Astrazeneca Ab
Below is the list of 10 most cited patents of Terns Pharmaceuticals:
| Publication Number | Citation Count |
| WO2022040600A1 | 88 |
| WO2021041237A1 | 35 |
| WO2020041741A1 | 35 |
| CN111320609A | 31 |
| WO2020123827A1 | 31 |
| WO2023049518A1 | 22 |
| WO2021050945A1 | 22 |
| WO2023164050A1 | 19 |
| WO2020077123A1 | 19 |
| WO2023076237A1 | 18 |
What Percentage of Terns Pharmaceuticals US Patent Applications Were Granted?
Terns Pharmaceuticals (Excluding its subsidiaries) has filed 34 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 7 have been granted leading to a grant rate of 38.89%
Below are the key stats of Terns Pharmaceuticalspatent prosecution at the USPTO.
Which Law Firms are managing US Patents for Terns Pharmaceuticals?
| Law Firm | Total Applications | Success Rate |
| Cooley Llp | 34 | 38.89% |
What are Terns Pharmaceuticals key innovation segments?
What Technologies are Covered by Terns Pharmaceuticals?
The chart below distributes patents filed by Terns Pharmaceuticals